Jean-Pierre Bassand Selected Research

Jean-Pierre Bassand Research Topics

Disease

30	Acute Coronary Syndrome 01/2020 - 07/2002
28	Hemorrhage 01/2022 - 04/2002
25	Stroke (Strokes) 01/2022 - 04/2006
24	Atrial Fibrillation 01/2022 - 01/2012
22	Myocardial Infarction 03/2014 - 04/2002
13	Thrombosis (Thrombus) 03/2014 - 03/2003
9	ST Elevation Myocardial Infarction 11/2010 - 04/2002
8	Embolism (Embolus) 01/2022 - 10/2009
4	Ischemia 03/2009 - 12/2005
4	Unstable Angina 12/2005 - 01/2003
3	Vascular Diseases (Vascular Disease) 02/2021 - 12/2019
3	Heart Failure 02/2021 - 12/2019
3	Hypertension (High Blood Pressure) 02/2021 - 01/2006
3	Infarction (Infarctions) 11/2011 - 03/2003
3	Pulmonary Embolism 10/2009 - 08/2003
2	Thromboembolism 02/2021 - 12/2019
2	Diabetes Mellitus 02/2021 - 12/2019
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 12/2019
2	Body Weight (Weight, Body) 08/2013 - 04/2006
2	Rupture 02/2013 - 03/2003
2	Stable Angina 10/2009 - 11/2007
2	Type 2 Diabetes Mellitus (MODY) 12/2006 - 01/2006
2	Hypercholesterolemia 12/2006 - 09/2004
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2006 - 01/2006
2	Venous Thrombosis (Deep-Vein Thrombosis) 12/2005 - 03/2005
1	Kidney Diseases (Kidney Disease) 01/2019
1	Cardiomyopathies (Cardiomyopathy) 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2012
1	Shock 10/2009
1	Cardiogenic Shock 10/2009
1	Syncope (Fainting) 10/2009
1	Albuminuria 02/2009
1	Venous Thromboembolism 11/2007
1	Coronary Disease (Coronary Heart Disease) 12/2006
1	Atherosclerosis 12/2006

Drug/Important Bio-Agent (IBA)

30	AnticoagulantsIBA 01/2022 - 11/2002
15	Fondaparinux (Arixtra)FDA Link 02/2010 - 03/2005
9	Enoxaparin (Lovenox)FDA LinkGeneric 02/2010 - 04/2002
8	Vitamin K FDA Link 02/2021 - 03/2012
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2014 - 12/2008
5	Factor Xa InhibitorsIBA 02/2021 - 03/2005
5	Thrombin FDA Link 03/2014 - 03/2005
5	Clopidogrel (Plavix)FDA Link 08/2013 - 07/2002
5	Heparin (Liquaemin)FDA LinkGeneric 11/2008 - 01/2003
4	AntithrombinsIBA 02/2021 - 04/2002
4	Factor Xa (Coagulation Factor Xa)IBA 07/2013 - 03/2005
4	TroponinIBA 10/2009 - 03/2003
3	Fibrinolytic Agents (Antithrombotic Agents)IBA 02/2013 - 02/2008
3	Pharmaceutical PreparationsIBA 10/2009 - 09/2004
2	N(4)-oleylcytosine arabinosideIBA 02/2021 - 01/2019
2	RivaroxabanIBA 07/2013 - 01/2012
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 03/2012 - 04/2006
2	C-Reactive ProteinIBA 02/2010 - 02/2009
2	P-SelectinIBA 10/2009 - 11/2007
2	Glycoproteins (Glycoprotein)IBA 10/2009 - 11/2007
2	MetalsIBA 10/2009 - 11/2007
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 03/2009 - 01/2003
2	Biological ProductsIBA 02/2009 - 02/2009
2	Glucose (Dextrose)FDA LinkGeneric 02/2009 - 01/2006
2	LDL CholesterolIBA 12/2006 - 01/2006
2	A-factor (Streptomyces)IBA 04/2006 - 12/2005
2	Abciximab (ReoPro)FDA Link 12/2005 - 08/2002
2	Tirofiban (Aggrastat)FDA Link 12/2005 - 08/2002
1	Prasugrel Hydrochloride FDA Link 08/2013
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 07/2013
1	Warfarin (Coumadin)FDA LinkGeneric 03/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2011
1	trichostatin A (A 300)IBA 09/2010
1	Fibrinogen (Factor I)FDA Link 10/2009
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2009
1	Prothrombin (Factor II)IBA 10/2009
1	Thromboplastin (Tissue Factor)IBA 10/2009
1	Plasminogen InactivatorsIBA 10/2009
1	Factor VIIa (Activated Factor VII)IBA 10/2009
1	omega-Chloroacetophenone (Mace)IBA 04/2009
1	CreatinineIBA 02/2009
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2009
1	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2009
1	Streptokinase FDA Link 02/2008
1	bivalirudin (Angiomax)FDA Link 05/2007
1	Adenosine Triphosphate (ATP)IBA 12/2006
1	Lipoproteins (Lipoprotein)IBA 12/2006
1	LipidsIBA 12/2006
1	Atorvastatin (Lipitor)FDA Link 12/2006
1	DEAE-Dextran (Pulsar)IBA 12/2006
1	Rosuvastatin Calcium (Crestor)FDA Link 12/2006
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2006
1	CholesterolIBA 12/2006
1	oxidized low density lipoproteinIBA 12/2006

Therapy/Procedure

29	Therapeutics 01/2021 - 04/2002
8	Percutaneous Coronary Intervention 08/2011 - 01/2003
5	Stents 07/2013 - 11/2007
3	Thrombolytic Therapy 02/2008 - 08/2003
2	Blood Transfusion (Blood Transfusions) 10/2009 - 05/2007
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2012
1	Length of Stay 10/2009
1	Contraindications 04/2009
1	Conservative Treatment 11/2008
1	Catheters 10/2007